FDA Tip Sparks SEC Biopure Investigation
A Securities and Exchange Commission lawsuit filed against medical technology company Biopure was prompted by a tip from the Food and Drug Administration, according to SEC officials....To view the full article, register now.
Already a subscriber? Click here to view full article